Fabtech Technologies has won a Rs. 49-52 crore contract to construct an EU GMP certified veterinary formulations facility in North Africa. The international client aims to export to EU and regional markets, with project completion expected by Q1 2027, marking a major step in Fabtech's global expansion.
Fabtech Technologies Ltd announced securing an international order from a leading upcoming veterinary manufacturing company in North Africa, which is set to be EU GMP certified. The contract involves building a next-generation veterinary formulations facility destined to export to the EU and neighboring African markets. This prestigious project, with a valued contract price ranging between Rs. 49 crores and Rs. 52 crores, underscores Fabtech's growing footprint in the global pharma manufacturing space. Execution is targeted for completion by Q1 2027, aligning with industry standards and confidentiality agreements, which have necessitated withholding the client’s name.
The contract reflects Fabtech’s strategic expansion into high-growth regions, leveraging advanced manufacturing expertise to meet international regulatory standards. The North African veterinary market's expansion, together with EU regulatory compliance, positions this project as a significant milestone for Fabtech in servicing global animal healthcare needs.
Notable Updates:
-
Fabtech awarded order by an EU GMP certified veterinary company in North Africa
-
Confidentiality maintained on client identity
-
Contract valued between Rs. 49-52 crore, exclusive of taxes
-
Facility to export to EU and neighboring African markets
-
Execution timeline set for completion by 1st quarter 2027
-
Order terms adhere to standard industry conditions
-
Order represents an international contract, expanding Fabtech’s global reach
Source: Fabtech Technologies Ltd official announcement